The basis of the measurement and valuation of benefits is one of the most controversial issues within health economics, and broader health services research. Research in this area covers the conceptual and methodological development of the benefit valuation techniques, and their application across a range of possible benefits in health care.

Examples of completed research

Comparing cost-utility estimates based on the EQ-5D to those based on mapping from a condition specific measure (the WOMAC) (Barton, Sach)

Comparing cost-utility estimates based on the EQ-5D to those based on the SF-6D (Sach, Barton)

Measuring the benefits of treatment for psychosis: The validity and responsiveness of the EQ-5D (Barton)

The ‘Social Value of a QALY' (SVQ), conducted for the National Institute for Clinical Excellence (NICE), together with the National Co-ordinating Centre for Research Methodology (NCCRM).  (Angela Robinson).

An empirical investigation as to the construct validity of the EQ-5D, SF-6D and EuroQol visual analogue scale (VAS) with regard to various socio-demographic factors and clinical conditions (Garry Barton and Tracey Sach).

The EuroVaQ project that was funded by the European Commission, and was a collaboration of researchers from 10 countries, the main aims being to develop more robust methods to determine the monetary value of a QALY based on surveys of the general public.  Two work packages were carried out by UEA (Angela Robinson).

Development of a capability-based measure of well being in chronic pain, for Philip Kinghorn's PhD thesis (Angela Robinson).